Development of Cell Lines for use in COVID-19 Drug Development and Research
Dela J Public Health
.
2021 Dec 15;7(5):32-35.
doi: 10.32481/djph.2021.12.009.
eCollection 2021 Dec.
Author
London McGill
1
Affiliation
1
Staff Scientist II, Gene Editing Institute, ChristianaCare.
PMID:
35619971
PMCID:
PMC9124558
DOI:
10.32481/djph.2021.12.009
No abstract available